UBS AM’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-284,371
Closed -$37.5M 2744
2025
Q1
$37.5M Sell
284,371
-50,948
-15% -$6.72M 0.01% 746
2024
Q4
$28M Buy
335,319
+12,111
+4% +$1.01M 0.01% 826
2024
Q3
$23.6M Buy
323,208
+11,104
+4% +$812K 0.01% 886
2024
Q2
$21.4M Buy
312,104
+81,194
+35% +$5.56M 0.01% 846
2024
Q1
$16M Buy
230,910
+16,629
+8% +$1.15M 0.01% 863
2023
Q4
$15.3M Buy
214,281
+4,346
+2% +$311K 0.01% 846
2023
Q3
$10.9M Buy
209,935
+4,623
+2% +$241K ﹤0.01% 926
2023
Q2
$11.1M Hold
205,312
0.01% 932
2023
Q1
$11.1M Buy
205,312
+4,599
+2% +$249K 0.01% 932
2022
Q4
$10.6M Buy
200,713
+14,881
+8% +$788K 0.01% 919
2022
Q3
$8.65M Sell
185,832
-55,669
-23% -$2.59M ﹤0.01% 1005
2022
Q2
$13.8M Sell
241,501
-5,733
-2% -$327K 0.01% 845
2022
Q1
$15.1M Buy
247,234
+174,038
+238% +$10.6M 0.01% 925
2021
Q4
$3.83M Sell
73,196
-10,550
-13% -$552K ﹤0.01% 1539
2021
Q3
$3.12M Buy
83,746
+3,845
+5% +$143K ﹤0.01% 1608
2021
Q2
$3.26M Buy
79,901
+12,693
+19% +$518K ﹤0.01% 1613
2021
Q1
$2.28M Sell
67,208
-436
-0.6% -$14.8K ﹤0.01% 1698
2020
Q4
$2.15M Buy
67,644
+15,942
+31% +$507K ﹤0.01% 1651
2020
Q3
$1.33M Buy
51,702
+5,114
+11% +$131K ﹤0.01% 1727
2020
Q2
$1.2M Buy
46,588
+45
+0.1% +$1.16K ﹤0.01% 1726
2020
Q1
$715K Buy
46,543
+7,930
+21% +$122K ﹤0.01% 1826
2019
Q4
$1.32M Sell
38,613
-1,968
-5% -$67.5K ﹤0.01% 1775
2019
Q3
$303K Buy
40,581
+9,117
+29% +$68.1K ﹤0.01% 2454
2019
Q2
$408K Buy
31,464
+1,144
+4% +$14.8K ﹤0.01% 2300
2019
Q1
$369K Buy
30,320
+15,620
+106% +$190K ﹤0.01% 2227
2018
Q4
$167K Hold
14,700
﹤0.01% 2442
2018
Q3
$319K Hold
14,700
﹤0.01% 2258
2018
Q2
$260K Hold
14,700
﹤0.01% 2362
2018
Q1
$309K Hold
14,700
﹤0.01% 2197
2017
Q4
$213K Buy
+14,700
New +$213K ﹤0.01% 2282
2016
Q4
Sell
-18,100
Closed -$276K 2685
2016
Q3
$276K Hold
18,100
﹤0.01% 2309
2016
Q2
$703K Hold
18,100
﹤0.01% 1796
2016
Q1
$503K Sell
18,100
-2,911
-14% -$80.9K ﹤0.01% 1916
2015
Q4
$1.13M Buy
21,011
+8,611
+69% +$464K ﹤0.01% 1690
2015
Q3
$496K Buy
12,400
+3,800
+44% +$152K ﹤0.01% 2023
2015
Q2
$275K Buy
+8,600
New +$275K ﹤0.01% 2416